| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $607K | -72.0% |
| Cost of Revenue | $405K | -68.0% |
| Gross Profit | $202K | -77.7% |
| R&D Expense | $394K | +336.2% |
| SG&A Expense | $2.1M | +69.8% |
| Operating Income | -$14.5M | -103.4% |
| Net Income | -$14.3M | -92.8% |
| EPS (Basic) | -$0.85 | -21.4% |
| EPS (Diluted) | -$0.85 | -21.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $100K | -19.1% |
| Inventory | $615K | +79.8% |
| Current Assets | $17.9M | +551.9% |
| Total Assets | $19.1M | +286.2% |
| Current Liabilities | $1.3M | +39.9% |
| Long-term Debt | $146K | +0.0% |
| Total Liabilities | $1.4M | +30.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.2M | -51.8% |
| Capital Expenditures | $49K | -23.5% |
| Investing Cash Flow | -$241K | +44.7% |
| Financing Cash Flow | $21.3M | +267.0% |
| Free Cash Flow | -$6.3M | -50.6% |
| $17.7M |
| +357.3% |